CIRS RD Briefing 53 – Factors influencing drug roll out to six mature markets

Objective: To review NASs first launched between 2005‐2010 and to determine their regulatory status as of 31 December 2012 in USA, Europe, Japan, Canada, Switzerland and Australia to identify the characteristics of these products.